These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8847295)

  • 21. Pharmacokinetics of erythropoietin following single-dose subcutaneous administration in preterm infants.
    Krishnan R; Shankaran S; Krishnan M; Kauffman RE; Kumar P; Lucena J
    Biol Neonate; 1996; 70(3):135-40. PubMed ID: 8894079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study.
    Soubasi V; Kremenopoulos G; Diamandi E; Tsantali C; Tsakiris D
    Pediatr Res; 1993 Nov; 34(5):675-9. PubMed ID: 8284109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients.
    Nielsen OJ
    Pharmacol Toxicol; 1990 Feb; 66(2):83-6. PubMed ID: 2315268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants.
    Chang L; Liu W; Liao C; Zhao X
    J Tongji Med Univ; 1998; 18(4):239-42. PubMed ID: 10806855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens.
    D'Cunha R; Schmidt R; Widness JA; Mock DM; Yan X; Cress GA; Kuruvilla D; Veng-Pedersen P; An G
    Eur J Pharm Sci; 2019 Oct; 138():105013. PubMed ID: 31340188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin and retinopathy of prematurity.
    Romagnoli C; Tesfagabir MG; Giannantonio C; Papacci P
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S39-42. PubMed ID: 21303729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of recombinant human erythropoietin on neutrophil function in premature neonates.
    Soubasi V; Roilides E; Tsantali C; Mussafiris K; Tsakiris D; Kremenopoulos G
    Cytokine; 1999 Jan; 11(1):61-5. PubMed ID: 10080880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial.
    Pasha YZ; Ahmadpour-Kacho M; Hajiahmadi M; Hosseini MB
    Indian Pediatr; 2008 Jan; 45(1):25-8. PubMed ID: 18250501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
    Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
    Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.
    Picotti E; Reinelt T; Koller B; Bucher HU; Rüegger CM; Fauchère JC; Natalucci G;
    JAMA Netw Open; 2022 Dec; 5(12):e2245499. PubMed ID: 36477478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of recombinant human erythropoietin on the development of retinopathy of prematurity.
    Shah N; Jadav P; Jean-Baptiste D; Weedon J; Cohen LM; Kim MR
    Am J Perinatol; 2010 Jan; 27(1):67-71. PubMed ID: 19565433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants.
    Kivivuori SM; Heikinheimo M; Teppo AM; Siimes MA
    Pediatr Res; 1994 Jul; 36(1 Pt 1):85-9. PubMed ID: 7936843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
    Melo AM; Costa MT; Porta V; Vaz FA
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral iron supplementation in preterm infants treated with erythropoietin.
    Fujiu T; Maruyama K; Koizumi T
    Pediatr Int; 2004 Dec; 46(6):635-9. PubMed ID: 15660859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin and prematurity--where do we stand?
    Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
    J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.